Journal of Medicinal Chemistry · 2013 · 63 citations · 56 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationAntibacterial PharmacologyFragment-based OptimizationAntagonistic InteractionsAntibiotic DiscoveryBiophysical CharacterizationDirected MutagenesisNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryOxadiazole ChemistryReporter Gene Assays
The human pathogen Pseudomonas aeruginosa employs alkyl quinolones for cell-to-cell communication. The Pseudomonas quinolone signal (PQS) regulates various virulence factors via interaction with the transcriptional regulator PqsR. Therefore, we consider the development of PqsR antagonists a novel strategy to limit the pathogenicity of P. aeruginosa. A fragment identification approach using surface plasmon resonance screening led to the discovery of chemically diverse PqsR ligands. The optimization of the most promising hit (5) resulted in the oxadiazole-2-amine 37 showing pure antagonistic activity in Escherichia coli (EC50 = 7.5 μM) and P. aeruginosa (EC50 = 38.5 μM) reporter gene assays. 37 was able to diminish the production of the PQS precursor HHQ in a PqsH-deficient P. aeruginosa mutant. The level of the major virulence factor pyocyanin was significantly reduced in wild-type P. aeruginosa. In addition, site-directed mutagenesis in combination with isothermal titration calorimetry and NMR INPHARMA experiments revealed that the identified ligands bind to the same site of PqsR by adopting different binding modes. These findings will be utilized in a future fragment-growing approach aiming at novel therapeutic options for the treatment of P. aeruginosa infections.
56
The Prevalence of Nosocomial Infection in Intensive Care Units in Europe
Jean‐Louis Vincent · JAMA · 1995 · 1.6K citations
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Morten Hentzer · The EMBO Journal · 2003 · 1.4K citations · Full text